Showing results (541-550 of 634) with videos related to
Sort By:
Pageof 64
Radiology. Artificial Intelligence|March 18, 2026
Transformer-based Fusion of Longitudinal Multimodal Radiomic Features from Chest Radiography and CT in COVID-19Chunrui Zou, Walter Mankowski, Lauren Pantalone, et al.Plos Pathogens|April 28, 2023
Glucuronoxylomannan intranasal challenge prior to Cryptococcus neoformans pulmonary infection enhances cerebral cryptococcosis in rodentsHiu Ham Lee, Dylan J Carmichael, Victoria Ríbeiro, et al.Annals of the American Thoracic Society|October 6, 2020
The Role of Imaging in the Management of Suspected or Known COVID-19 Pneumonia: A Multidisciplinary PerspectiveLeonid Roshkovan, Neil Chatterjee, Maya Galperin-Aizenberg, et al.Annals of the American Thoracic Society|October 30, 2020
The Role of Imaging in the Management of Suspected or Known COVID-19 Pneumonia. A Multidisciplinary PerspectiveLeonid Roshkovan, Neil Chatterjee, Maya Galperin-Aizenberg, et al.Scientific Reports|May 12, 2021
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitorsBardia Yousefi, Michael J LaRiviere, Eric A Cohen, et al.JAMA Network Open|January 30, 2026
Traumatic Brain Injury and All-Cause and Dementia-Related Mortality in the Framingham Heart StudyRebecca Burton, Shruti Durape, Eden Price, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersChad William Farris, Shruti Durape, Rebecca Burton, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumChad William Farris, Shruti Durape, Rebecca Burton, et al.The New England Journal of Medicine|March 2, 2012
Placebo-controlled trial of amantadine for severe traumatic brain injuryJoseph T Giacino, John Whyte, Emilia Bagiella, et al.Scientific Reports|June 15, 2022
Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapyApurva Singh, Hannah Horng, Leonid Roshkovan, et al.Pageof 64